Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

What are the immunomodulatory properties of cannabis’ cannabinoids in PMR? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Cannabis’ cannabinoids have shown potential in modulating immune responses, which may be relevant for managing cannabinoids immune effects on PMR. Understanding these properties can help in exploring alternative or complementary therapies for patients experiencing inflammation and immune-related symptoms. 

Can cannabis help my symptoms?

Immune Modulation and Inflammation 

The interaction of cannabinoids with the immune system may influence inflammatory pathways that contribute to PMR symptoms. 

Inflammation Regulation 

Inflammation regulation by cannabinoids helps reduce pro-inflammatory cytokines, potentially easing stiffness and pain associated with PMR. These effects are central to the observed cannabinoids immune effects on PMR. 

Immune System Modulation 

Immune system modulation occurs through cannabinoids interacting with CB1 and CB2 receptors, which can alter immune cell activity and promote a balanced immune response. This contributes to reduced flare-ups and symptom severity in PMR patients. 

Anti-Inflammatory Cannabinoids 

Certain anti-inflammatory cannabinoids like CBD demonstrate immunomodulatory properties without producing psychoactive effects, highlighting the therapeutic potential of targeted cannabis interventions for PMR. 

Overall, cannabinoids immune effects on PMR suggest that cannabis may offer supportive benefits through inflammation regulation, immune system modulation, and the use of anti-inflammatory cannabinoids. While more clinical research is needed, these properties provide a promising basis for adjunctive therapies in PMR management. 

If you’re exploring cannabis treatment options for polymyalgia rheumatica, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and polymyalgia rheumatica. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories